Retractions follow revelations of misconduct by diabetes biotech

Several months after a drug company cancelled development of a potential diabetes cure because it found evidence that a biotech they had recently acquired had committed misconduct in studies of the drug, two retractions of relevant studies have appeared. The research involves DiaPep277, which, as Josh Levy explained here in September, “would cause the immune system … Continue reading Retractions follow revelations of misconduct by diabetes biotech

Authors retract green coffee bean diet paper touted by Dr. Oz

Two authors of a 2012 paper sponsored by a company that made grand claims about green coffee bean extract’s abilities to help people lose weight have retracted it. The study was cited by The Dr. Oz Show, and last month it cost the company a $3.5 million settlement with the Feds. Here’s the notice for … Continue reading Authors retract green coffee bean diet paper touted by Dr. Oz

Scientist threatening to sue PubPeer claims he lost a job offer because of comments

Last month, PubPeer announced that a scientist had threatened to sue the site for defamation. At the time, all PubPeer would say was that the “prospective plaintiff” is a US researcher” who was “aggrieved at the treatment his papers are getting on our site.” Today, PubPeer revealed the that the prospective plaintiff was Fazlul Sarkar, … Continue reading Scientist threatening to sue PubPeer claims he lost a job offer because of comments

Science retracts two papers for image manipulation

Science has retracted two papers by Frank Sauer, of the University of California, Riverside, after the university found evidence of serious image manipulation. Here’s the notice, signed by Science editor-in-chief Marcia McNutt:

Weekend reads: Retraction Watch on NPR; “hysteria” over replication; when a paywall might be a good thing

It’s been another busy week at Retraction Watch, mostly because of the unfolding Jens Förster story. Here’s what was happening elsewhere on the web:

Weekend reads: Self-plagiarism and moral panic; sexism in science; peer review under scrutiny

Another busy week at Retraction Watch, which kicked off with our announcement that we’re hiring a paid intern. Here’s what was happening elsewhere around the web:

Publisher to pulp existing copies of science communication book because of plagiarism

The publisher Taylor & Francis has decided to pulp all existing copies of a 2012 book on science communication, and suspend electronic copies indefinitely, after it became clear that the text was plagiarized from the work of another author. The book, Clear and Concise Communications for Scientists and Engineers, was written by energy and environmental … Continue reading Publisher to pulp existing copies of science communication book because of plagiarism

Fraud fells Alzheimer’s “made to order” neurons paper in Cell

In 2011, a group of researchers at Columbia University reported in Cell that they had been able to convert skin cells from patients with Alzheimer’s disease into functioning neurons — a finding that raised the exciting prospect of “made to order” brain cells for patients with the degenerative disease. As one researcher not involved with … Continue reading Fraud fells Alzheimer’s “made to order” neurons paper in Cell

March Madness? Harvard profs take shots at controversial studies, request retractions

In the wake of Harvard’s gritty performance in the NCAA men’s basketball tournament — they were eliminated Saturday — a pair of faculty members at the Ivy League institution are calling foul on two controversial journal articles that have already been corrected. Walter Willett, an oft-quoted Harvard nutrition expert, is calling for the retraction of … Continue reading March Madness? Harvard profs take shots at controversial studies, request retractions